A carregar...
C‐Jun N‐terminal kinase signalling pathway in response to cisplatin
Cisplatin (cis diamminedichloroplatinum II, cDDP) is one of the most effective cancer chemotherapeutic agents and is used in the treatment of many types of human malignancies. However, inherent tumour resistance is a major barrier to effective cisplatin therapy. So far, the mechanism of cDDP resista...
Na minha lista:
| Publicado no: | J Cell Mol Med |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5082413/ https://ncbi.nlm.nih.gov/pubmed/27374471 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.12908 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|